P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL-1)

• M.C. Minnema,
• A. Chari,
• C. Touzeau,
• C. Schinke,
• J. Berdeja,
• A. Oriol,
• de Donk N. van,
• P.R. Otero,
• E. Askari,
• M.V. Mateos,
• L.J. Costa,
• J. Caers,
• L. Rasche,
• A. Krishnan,
• D. Vishwamitra,
• X. Ma,
• X. Qin,
• K.S. Gries,
• M. Campagna,
• T. Masterson,
• B. Hilder,
• J. Tolbert,
• T. Renaud,
• J.D. Goldberg,
• C. Heuck,
• J.S. Miguel,
• P. Moreau

Affiliations

M.C. Minnema

1 University Medical Center, Utrecht, the Netherlands

A. Chari

2 Mount Sinai School of Medicine, New York, NJ

C. Touzeau

3 Centre Hospitalier Universitaire de Nantes, Nantes, France

C. Schinke

4 Myeloma Center, University of Arkansas for Medical Sciences Little Rock, Arkansas

J. Berdeja

5 Sarah Cannon Research Institute, Nashville, TN

A. Oriol

6 Hospital Germans Trias I Pujol, Barcelona, Spain

de Donk N. van

7 Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, the Netherlands

P.R. Otero

8 University of Navarra, Pamplona, Spain

E. Askari

9 Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

M.V. Mateos

10 University Hospital of Salamanca/IBSAL/CIC, Salamanca, Spain

L.J. Costa

11 University of Alabama at Birmingham, Birmingham, United Kingdom

J. Caers

12 University of Liege, Liege, Belgium

L. Rasche

13 University Hospital of Würzburg, Würzburg, Germany

A. Krishnan

14 City of Hope Comprehensive Cancer Center, Duarte, CA

D. Vishwamitra

15 Janssen Research & Development, Spring House, PA

X. Ma

15 Janssen Research & Development, Spring House, PA

X. Qin

15 Janssen Research & Development, Spring House, PA

K.S. Gries

16 Janssen Global Services, Raritan, NJ

M. Campagna

17 Janssen-Cilag, Madrid, Spain

T. Masterson

15 Janssen Research & Development, Spring House, PA

B. Hilder

15 Janssen Research & Development, Spring House, PA

J. Tolbert

15 Janssen Research & Development, Spring House, PA

T. Renaud

18 Janssen Research & Development, Raritan, NJ

J.D. Goldberg

18 Janssen Research & Development, Raritan, NJ

C. Heuck

15 Janssen Research & Development, Spring House, PA

J.S. Miguel

19 Universidad de Navarra, Pamplona, Spain

P. Moreau

20 University Hospital Hôtel-Dieu, Nantes, France